-
1
-
-
0028903101
-
Lysophosphatidic acid signalling
-
Moolenaar WH: Lysophosphatidic acid signalling. Curr Opin Cell Biol 7: 203-210, 1995.
-
(1995)
Curr Opin Cell Biol
, vol.7
, pp. 203-210
-
-
Moolenaar, W.H.1
-
3
-
-
0024428410
-
Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
-
van Corven EJ, Groenink A, Jalink K, Eichholtz T and Moolenaar WH: Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59: 45-54, 1989.
-
(1989)
Cell
, vol.59
, pp. 45-54
-
-
Van Corven, E.J.1
Groenink, A.2
Jalink, K.3
Eichholtz, T.4
Moolenaar, W.H.5
-
4
-
-
0028038495
-
Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta
-
Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M and Tanaka S: Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol 267: C204-C210, 1994.
-
(1994)
Am J Physiol
, vol.267
-
-
Tokumura, A.1
Iimori, M.2
Nishioka, Y.3
Kitahara, M.4
Sakashita, M.5
Tanaka, S.6
-
5
-
-
0026795116
-
Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells
-
Tigyi G and Miledi R: Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem 267: 21360-21367, 1992.
-
(1992)
J Biol Chem
, vol.267
, pp. 21360-21367
-
-
Tigyi, G.1
Miledi, R.2
-
6
-
-
0027583540
-
Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: Similarity to thrombin action
-
Jalink K, Eichholtz T, Postma FR, van Corven EJ and Moolenaar WH: Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action. Cell Growth Differ 4: 247-255, 1993.
-
(1993)
Cell Growth Differ
, vol.4
, pp. 247-255
-
-
Jalink, K.1
Eichholtz, T.2
Postma, F.R.3
Van Corven, E.J.4
Moolenaar, W.H.5
-
7
-
-
0028004034
-
Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid
-
Zhang Q, Checovich WJ, Peters DM, Albrecht RM and Mosher DF: Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid. J Cell Biol 127: 1447-1459, 1994.
-
(1994)
J Cell Biol
, vol.127
, pp. 1447-1459
-
-
Zhang, Q.1
Checovich, W.J.2
Peters, D.M.3
Albrecht, R.M.4
Mosher, D.F.5
-
8
-
-
0029032202
-
Lysophosphatidic acid, a multifunctional phospholipid messenger
-
Moolenaar WH: Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270: 12949-12952, 1995.
-
(1995)
J Biol Chem
, vol.270
, pp. 12949-12952
-
-
Moolenaar, W.H.1
-
9
-
-
0042887042
-
The emerging role of lysophosphatidic acid in cancer
-
Mills GB and Moolenaar WH: The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3: 582-591, 2003.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 582-591
-
-
Mills, G.B.1
Moolenaar, W.H.2
-
10
-
-
0034015046
-
Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer
-
Fang X, Gaudette D, Furui T, Mao M, Estrella V, Eder A, Pustilnik T, et al: Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann NY Acad Sci 905: 188-208, 2000.
-
(2000)
Ann NY Acad Sci
, vol.905
, pp. 188-208
-
-
Fang, X.1
Gaudette, D.2
Furui, T.3
Mao, M.4
Estrella, V.5
Eder, A.6
Pustilnik, T.7
-
11
-
-
0034083409
-
Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2
-
Eder AM, Sasagawa T, Mao M, Aoki J and Mills GB: Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin Cancer Res 6: 2482-2491, 2000.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2482-2491
-
-
Eder, A.M.1
Sasagawa, T.2
Mao, M.3
Aoki, J.4
Mills, G.B.5
-
12
-
-
0035300534
-
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells
-
Fishman DA, Liu Y, Ellerbroek SM and Stack MS: Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res 61: 3194-3199, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 3194-3199
-
-
Fishman, D.A.1
Liu, Y.2
Ellerbroek, S.M.3
Stack, M.S.4
-
13
-
-
10744225477
-
Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells
-
Fang X, Yu S, Bast RC, Liu S, Xu HJ, Hu SX, LaPushin R, et al: Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J Biol Chem 279: 9653-9661, 2004.
-
(2004)
J Biol Chem
, vol.279
, pp. 9653-9661
-
-
Fang, X.1
Yu, S.2
Bast, R.C.3
Liu, S.4
Xu, H.J.5
Hu, S.X.6
LaPushin, R.7
-
14
-
-
0027232391
-
The bioactive phospholipid lysophosphatidic acid is released from activated platelets
-
Eichholtz T, Jalink K, Fahrenfort I and Moolenaar WH: The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291: 677-680, 1993.
-
(1993)
Biochem J
, vol.291
, pp. 677-680
-
-
Eichholtz, T.1
Jalink, K.2
Fahrenfort, I.3
Moolenaar, W.H.4
-
15
-
-
0032569235
-
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
-
Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, et al: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280: 719-723, 1998.
-
(1998)
JAMA
, vol.280
, pp. 719-723
-
-
Xu, Y.1
Shen, Z.2
Wiper, D.W.3
Wu, M.4
Morton, R.E.5
Elson, P.6
Kennedy, A.W.7
-
16
-
-
0029126484
-
Lysophospholipids activate ovarian and breast cancer cells
-
Xu Y, Fang XJ, Casey G and Mills GB: Lysophospholipids activate ovarian and breast cancer cells. Biochem J 309: 933-940, 1995.
-
(1995)
Biochem J
, vol.309
, pp. 933-940
-
-
Xu, Y.1
Fang, X.J.2
Casey, G.3
Mills, G.B.4
-
17
-
-
0031747415
-
Malignant effusions contain lysophosphatidic acid (LPA)-like activity
-
Westermann AM, Havik E, Postma FR, Beijnen JH, Dalesio O, Moolenaar WH and Rodenhuis S: Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol 9: 437-442, 1998.
-
(1998)
Ann Oncol
, vol.9
, pp. 437-442
-
-
Westermann, A.M.1
Havik, E.2
Postma, F.R.3
Beijnen, J.H.4
Dalesio, O.5
Moolenaar, W.H.6
Rodenhuis, S.7
-
18
-
-
0024495699
-
Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin
-
Gerrard JM and Robinson P: Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta 1001: 282-285, 1989.
-
(1989)
Biochim Biophys Acta
, vol.1001
, pp. 282-285
-
-
Gerrard, J.M.1
Robinson, P.2
-
19
-
-
1542359873
-
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
-
Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, et al: Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158: 227-233, 2002.
-
(2002)
J Cell Biol
, vol.158
, pp. 227-233
-
-
Umezu-Goto, M.1
Kishi, Y.2
Taira, A.3
Hama, K.4
Dohmae, N.5
Takio, K.6
Yamori, T.7
Mills, G.B.8
-
20
-
-
0037374562
-
The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: Validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer
-
Tanyi JL, Morris AJ, Wolf JK, Fang X, Hasegawa Y, Lapushin R, Auersperg N, et al: The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res 63: 1073-1082, 2003.
-
(2003)
Cancer Res
, vol.63
, pp. 1073-1082
-
-
Tanyi, J.L.1
Morris, A.J.2
Wolf, J.K.3
Fang, X.4
Hasegawa, Y.5
Lapushin, R.6
Auersperg, N.7
-
21
-
-
0034700050
-
Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior
-
Contos JJ, Fukushima N, Weiner JA, Kaushal D and Chun J: Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 97: 13384-13389, 2000.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 13384-13389
-
-
Contos, J.J.1
Fukushima, N.2
Weiner, J.A.3
Kaushal, D.4
Chun, J.5
-
22
-
-
0036786445
-
Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: Signaling deficits without obvious phenotypic abnormality attributable to lpa(2)
-
Contos JJ, Ishii I, Fukushima N, Kingsbury MA, Ye X, Kawamura S, Brown JH and Chun J: Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol Cell Biol 22: 6921-6929, 2002.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 6921-6929
-
-
Contos, J.J.1
Ishii, I.2
Fukushima, N.3
Kingsbury, M.A.4
Ye, X.5
Kawamura, S.6
Brown, J.H.7
Chun, J.8
-
23
-
-
0942301169
-
Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)
-
Huang MC, Lee HY, Yeh CC, Kong Y, Zaloudek CJ and Goetzl EJ: Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2). Oncogene 23: 122-129, 2004.
-
(2004)
Oncogene
, vol.23
, pp. 122-129
-
-
Huang, M.C.1
Lee, H.Y.2
Yeh, C.C.3
Kong, Y.4
Zaloudek, C.J.5
Goetzl, E.J.6
-
24
-
-
0031788478
-
Activation of c-Jun N-terminal kinase (JNK) by lysophosphatidic acid in Swiss 3T3 fibroblasts
-
Sasaki T, Maehama T, Yamamoto T, Takasuga S, Hoshino S, Nishina H, Hazeki O, et al: Activation of c-Jun N-terminal kinase (JNK) by lysophosphatidic acid in Swiss 3T3 fibroblasts. J Biochem 124: 934-939, 1998.
-
(1998)
J Biochem
, vol.124
, pp. 934-939
-
-
Sasaki, T.1
Maehama, T.2
Yamamoto, T.3
Takasuga, S.4
Hoshino, S.5
Nishina, H.6
Hazeki, O.7
-
25
-
-
0030044360
-
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
-
Daub H, Weiss FU, Wallasch C and Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560, 1996.
-
(1996)
Nature
, vol.379
, pp. 557-560
-
-
Daub, H.1
Weiss, F.U.2
Wallasch, C.3
Ullrich, A.4
-
26
-
-
0028977847
-
Receptor-tyrosine-kinase- And G beta gamma-mediated MAP kinase activation by a common signalling pathway
-
van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, et al: Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature 376: 781-784, 1995.
-
(1995)
Nature
, vol.376
, pp. 781-784
-
-
Van Biesen, T.1
Hawes, B.E.2
Luttrell, D.K.3
Krueger, K.M.4
Touhara, K.5
Porfiri, E.6
Sakaue, M.7
-
27
-
-
0029778177
-
Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases
-
Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing TJ and Lefkowitz RJ: Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271: 19443-19450, 1996.
-
(1996)
J Biol Chem
, vol.271
, pp. 19443-19450
-
-
Luttrell, L.M.1
Hawes, B.E.2
Van Biesen, T.3
Luttrell, D.K.4
Lansing, T.J.5
Lefkowitz, R.J.6
-
28
-
-
0030765077
-
Stress-activated protein kinases: Activation, regulation and function
-
Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW and Plevin R: Stress-activated protein kinases: activation, regulation and function. Cell Signal 9: 403-410, 1997.
-
(1997)
Cell Signal
, vol.9
, pp. 403-410
-
-
Paul, A.1
Wilson, S.2
Belham, C.M.3
Robinson, C.J.4
Scott, P.H.5
Gould, G.W.6
Plevin, R.7
-
29
-
-
0028908979
-
Lysophosphatidic acid induction of transforming growth factors alpha and beta: Modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin
-
Piazza GA, Ritter JL and Baracka CA: Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp Cell Res 216: 51-64, 1995.
-
(1995)
Exp Cell Res
, vol.216
, pp. 51-64
-
-
Piazza, G.A.1
Ritter, J.L.2
Baracka, C.A.3
-
30
-
-
0032712996
-
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
-
Pustilnik TB, Estrella V, Wiener JR, Mao M, Eder A, Watt MA, Bast RC Jr, et al: Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin Cancer Res 5: 3704-3710, 1999.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 3704-3710
-
-
Pustilnik, T.B.1
Estrella, V.2
Wiener, J.R.3
Mao, M.4
Eder, A.5
Watt, M.A.6
Bast Jr., R.C.7
-
31
-
-
0021780949
-
Plasminogen activators, tissue degradation and cancer
-
Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS and Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139-266, 1985.
-
(1985)
Adv Cancer Res
, vol.44
, pp. 139-266
-
-
Dano, K.1
Andreasen, P.A.2
Grondahl-Hansen, J.3
Kristensen, P.4
Nielsen, L.S.5
Skriver, L.6
-
32
-
-
0029079407
-
The urokinase/urokinase-receptor system and cancer invasion
-
Conese M and Blasi F: The urokinase/urokinase-receptor system and cancer invasion. Baillieres Clin Haematol 8: 365-389, 1995.
-
(1995)
Baillieres Clin Haematol
, vol.8
, pp. 365-389
-
-
Conese, M.1
Blasi, F.2
-
33
-
-
0030002073
-
Proteases as prognostic markers in cancer
-
Duffy MJ: Proteases as prognostic markers in cancer. Clin Cancer Res 2: 613-618, 1996.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 613-618
-
-
Duffy, M.J.1
-
34
-
-
0026517693
-
Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin
-
van Corven EJ, van Rijswijk A, Jalink K, van der Bend RL, van Blitterswijk WJ and Moolenaar WH: Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem J 281: 163-169, 1992.
-
(1992)
Biochem J
, vol.281
, pp. 163-169
-
-
Van Corven, E.J.1
Van Rijswijk, A.2
Jalink, K.3
Van Der Bend, R.L.4
Van Blitterswijk, W.J.5
Moolenaar, W.H.6
-
35
-
-
0033555721
-
PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor
-
Takeda H, Matozaki T, Takada T, Noguchi T, Yamao T, Tsuda M, Ochi F, et al: PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor. EMBO J 18: 386-395, 1999.
-
(1999)
EMBO J
, vol.18
, pp. 386-395
-
-
Takeda, H.1
Matozaki, T.2
Takada, T.3
Noguchi, T.4
Yamao, T.5
Tsuda, M.6
Ochi, F.7
-
36
-
-
0028907221
-
Molecular cloning of human p38 MAP kinase
-
Han J, Richter B, Li Z, Kravchenko V and Ulevitch RJ: Molecular cloning of human p38 MAP kinase. Biochim Biophys Acta 1265: 224-227, 1995.
-
(1995)
Biochim Biophys Acta
, vol.1265
, pp. 224-227
-
-
Han, J.1
Richter, B.2
Li, Z.3
Kravchenko, V.4
Ulevitch, R.J.5
-
37
-
-
0030959278
-
Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity
-
Fang X, Gibson S, Flowers M, Furui T, Bast RC Jr and Mills GB: Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity. J Biol Chem 272: 13683-13689, 1997.
-
(1997)
J Biol Chem
, vol.272
, pp. 13683-13689
-
-
Fang, X.1
Gibson, S.2
Flowers, M.3
Furui, T.4
Bast Jr., R.C.5
Mills, G.B.6
-
38
-
-
0030737427
-
G-Protein-coupled receptors and Fcgamma-receptors mediate activation of Akt/protein kinase B in human phagocytes
-
Tilton B, Andjelkovic M, Didichenko SA, Hemmings BA and Thelen M: G-Protein-coupled receptors and Fcgamma-receptors mediate activation of Akt/protein kinase B in human phagocytes. J Biol Chem 272: 28096-28101, 1997.
-
(1997)
J Biol Chem
, vol.272
, pp. 28096-28101
-
-
Tilton, B.1
Andjelkovic, M.2
Didichenko, S.A.3
Hemmings, B.A.4
Thelen, M.5
-
39
-
-
0029043582
-
How MAP kinases are regulated
-
Cobb MH and Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
-
(1995)
J Biol Chem
, vol.270
, pp. 14843-14846
-
-
Cobb, M.H.1
Goldsmith, E.J.2
-
40
-
-
0030970723
-
Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src
-
Staley CA, Parikh NU and Gallick GE: Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth Differ 8: 269-274, 1997.
-
(1997)
Cell Growth Differ
, vol.8
, pp. 269-274
-
-
Staley, C.A.1
Parikh, N.U.2
Gallick, G.E.3
-
41
-
-
0032812095
-
Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model
-
Wiener JR, Nakano K, Kruzelock RP, Bucana CD, Bast RC Jr and Gallick GE: Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Clin Cancer Res 5: 2164-2170, 1999. (Pubitemid 29399273)
-
(1999)
Clinical Cancer Research
, vol.5
, Issue.8
, pp. 2164-2170
-
-
Wiener, J.R.1
Nakano, K.2
Kruzelock, R.P.3
Bucana, C.D.4
Bast Jr., R.C.5
Gallick, G.E.6
-
42
-
-
0034726004
-
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
-
Bandoh K, Aoki J, Taira A, Tsujimoto M, Arai H and Inoue K: Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett 478: 159-165, 2000.
-
(2000)
FEBS Lett
, vol.478
, pp. 159-165
-
-
Bandoh, K.1
Aoki, J.2
Taira, A.3
Tsujimoto, M.4
Arai, H.5
Inoue, K.6
-
43
-
-
0037809241
-
Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor
-
Hasegawa Y, Erickson JR, Goddard GJ, Yu S, Liu S, Cheng KW, Eder A, et al: Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor. J Biol Chem 278: 11962-11969, 2003.
-
(2003)
J Biol Chem
, vol.278
, pp. 11962-11969
-
-
Hasegawa, Y.1
Erickson, J.R.2
Goddard, G.J.3
Yu, S.4
Liu, S.5
Cheng, K.W.6
Eder, A.7
-
44
-
-
0030907226
-
Lysophosphatidic acid: G-protein signalling and cellular responses
-
DOI 10.1016/S0955-0674(97)80059-2
-
Moolenaar WH, Kranenburg O, Postma FR and Zondag GC: Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 9: 168-173, 1997. (Pubitemid 27135983)
-
(1997)
Current Opinion in Cell Biology
, vol.9
, Issue.2
, pp. 168-173
-
-
Moolenaar, W.H.1
Kranenburg, O.2
Postma, F.R.3
Zondag, G.C.M.4
-
45
-
-
0038364216
-
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
-
DOI 10.1023/A:1023099415940
-
Sidenius N and Blasi F: The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22: 205-222, 2003. (Pubitemid 36561058)
-
(2003)
Cancer and Metastasis Reviews
, vol.22
, Issue.2-3
, pp. 205-222
-
-
Sidenius, N.1
Blasi, F.2
-
46
-
-
0027234706
-
The plasminogen-activation system in ovarian tumors
-
Pujade-Lauraine E, Lu H, Mirshahi S, Soria J, Soria C, Bernadou A, Kruithof EK, et al: The plasminogen-activation system in ovarian tumors. Int J Cancer 55: 27-31, 1993.
-
(1993)
Int J Cancer
, vol.55
, pp. 27-31
-
-
Pujade-Lauraine, E.1
Lu, H.2
Mirshahi, S.3
Soria, J.4
Soria, C.5
Bernadou, A.6
Kruithof, E.K.7
-
47
-
-
0742307276
-
Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression
-
Murthi P, Barker G, Nowell CJ, Rice GE, Baker MS, Kalionis B and Quinn MA: Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression. Gynecol Oncol 92: 80-88, 2004.
-
(2004)
Gynecol Oncol
, vol.92
, pp. 80-88
-
-
Murthi, P.1
Barker, G.2
Nowell, C.J.3
Rice, G.E.4
Baker, M.S.5
Kalionis, B.6
Quinn, M.A.7
-
48
-
-
0034892043
-
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
-
Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, Fridman R, et al: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7: 2396-2404, 2001.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2396-2404
-
-
Schmalfeldt, B.1
Prechtel, D.2
Harting, K.3
Spathe, K.4
Rutke, S.5
Konik, E.6
Fridman, R.7
-
49
-
-
0035874046
-
Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)
-
DOI 10.1002/ijc.1215
-
Borgfeldt C, Hansson SR, Gustavsson B, Masback A and Casslen B: Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1). Int J Cancer 92: 497-502, 2001. (Pubitemid 32319422)
-
(2001)
International Journal of Cancer
, vol.92
, Issue.4
, pp. 497-502
-
-
Borgfeldt, C.1
Hansson, S.R.2
Gustavsson, B.3
Masback, A.4
Casslen, B.5
-
50
-
-
0028656476
-
Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy
-
Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Janicke F and Graeff H: Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy. Gynecol Oncol 55: 401-409, 1994.
-
(1994)
Gynecol Oncol
, vol.55
, pp. 401-409
-
-
Kuhn, W.1
Pache, L.2
Schmalfeldt, B.3
Dettmar, P.4
Schmitt, M.5
Janicke, F.6
Graeff, H.7
-
51
-
-
0034901514
-
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer
-
Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, Hepp H, et al: Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer. Clin Cancer Res 7: 1743-1749, 2001.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1743-1749
-
-
Konecny, G.1
Untch, M.2
Pihan, A.3
Kimmig, R.4
Gropp, M.5
Stieber, P.6
Hepp, H.7
-
52
-
-
0032582802
-
Urokinase induces proliferation of human ovarian cancer cells: Characterization of structural elements required for growth factor function
-
Fischer K, Lutz V, Wilhelm O, Schmitt M, Graeff H, Heiss P, Nishiguchi T, et al: Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function. FEBS Lett 438: 101-105, 1998.
-
(1998)
FEBS Lett
, vol.438
, pp. 101-105
-
-
Fischer, K.1
Lutz, V.2
Wilhelm, O.3
Schmitt, M.4
Graeff, H.5
Heiss, P.6
Nishiguchi, T.7
-
53
-
-
0033179049
-
Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type- plasminogen-activator N-terminal fragment
-
DOI 10.1042/0264-6021:3410765
-
Fishman DA, Kearns A, Larsh S, Enghild JJ and Stack MS: Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment. Biochem J 341: 765-769, 1999. (Pubitemid 29389209)
-
(1999)
Biochemical Journal
, vol.341
, Issue.3
, pp. 765-769
-
-
Fishman, D.A.1
Kearns, A.2
Larsh, S.3
Enghild, J.J.4
Stack, M.S.5
-
54
-
-
0035911966
-
Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin
-
DOI 10.1083/jcb.152.6.1145
-
Kjoller L and Hall A: Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J Cell Biol 152: 1145-1157, 2001. (Pubitemid 34280173)
-
(2001)
Journal of Cell Biology
, vol.152
, Issue.6
, pp. 1145-1157
-
-
Kjoller, L.1
Hall, A.2
-
55
-
-
0029007784
-
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice
-
Wilhelm O, Schmitt M, Hohl S, Senekowitsch R and Graeff H: Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice. Clin Exp Metastasis 13: 296-302, 1995.
-
(1995)
Clin Exp Metastasis
, vol.13
, pp. 296-302
-
-
Wilhelm, O.1
Schmitt, M.2
Hohl, S.3
Senekowitsch, R.4
Graeff, H.5
-
56
-
-
0037174147
-
High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: Effects on tumor growth and spread
-
Sato S, Kopitz C, Schmalix WA, Muehlenweg B, Kessler H, Schmitt M, Kruger A, et al: High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread. FEBS Lett 528: 212-216, 2002.
-
(2002)
FEBS Lett
, vol.528
, pp. 212-216
-
-
Sato, S.1
Kopitz, C.2
Schmalix, W.A.3
Muehlenweg, B.4
Kessler, H.5
Schmitt, M.6
Kruger, A.7
-
57
-
-
0037431429
-
Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin
-
Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, et al: Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin. Int J Cancer 104: 289-302, 2003.
-
(2003)
Int J Cancer
, vol.104
, pp. 289-302
-
-
Suzuki, M.1
Kobayashi, H.2
Tanaka, Y.3
Hirashima, Y.4
Kanayama, N.5
Takei, Y.6
Saga, Y.7
-
58
-
-
0031960208
-
Thrombin activates two stress-activated protein kinases, c-Jun N- Terminal kinase and p38, in HepG2 cells
-
DOI 10.1002/hep.510270524
-
Mitsui H, Maruyama T, Kimura S and Takuwa Y: Thrombin activates two stress-activated protein kinases, c-Jun N-terminal kinase and p38, in HepG2 cells. Hepatology 27: 1362-1367, 1998. (Pubitemid 28227865)
-
(1998)
Hepatology
, vol.27
, Issue.5
, pp. 1362-1367
-
-
Mitsui, H.1
Maruyama, T.2
Kimura, S.3
Takuwa, Y.4
-
59
-
-
0027170176
-
RapV12 antagonizes ras-dependent activation of ERK1 and ERK2 by LPA and EGF in rat-1 fibroblasts
-
Cook SJ, Rubinfeld B, Albert I and McCormick F: RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J 12: 3475-3485, 1993. (Pubitemid 23256435)
-
(1993)
EMBO Journal
, vol.12
, Issue.9
, pp. 3475-3485
-
-
Cook, S.J.1
Rubinfeld, B.2
Albert, I.3
McCormick, F.4
-
60
-
-
0031037296
-
Linkage of g protein-coupled receptors to the MAPK signaling pathway through Pl 3-kinase gamma
-
DOI 10.1126/science.275.5298.394
-
Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS and Wetzker R: Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 275: 394-397, 1997. (Pubitemid 27051618)
-
(1997)
Science
, vol.275
, Issue.5298
, pp. 394-397
-
-
Lopez-Ilasaca, M.1
Crespo, P.2
Pellici, P.G.3
Gutkind, J.S.4
Wetzker, R.5
-
61
-
-
0031725052
-
A function for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in fibroblasts during mitogenesis: Requirement for insulin- And lysophosphatidic acid-mediated signal transduction
-
Roche S, Downward J, Raynal P and Courtneidge SA: A function for phosphatidylinositol 3-kinase beta (p85alphap110beta) in fibroblasts during mitogenesis: requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol Cell Biol 18: 7119-7129, 1998. (Pubitemid 28533031)
-
(1998)
Molecular and Cellular Biology
, vol.18
, Issue.12
, pp. 7119-7129
-
-
Roche, S.1
Downward, J.2
Raynal, P.3
Courtneidge, S.A.4
-
62
-
-
9644262476
-
P38 mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression
-
DOI 10.1074/jbc.M409221200
-
Yu J, Bian D, Mahanivong C, Cheng RK, Zhou W and Huang S: p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J Biol Chem 279: 50446-50454, 2004. (Pubitemid 39577863)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.48
, pp. 50446-50454
-
-
Yu, J.1
Bian, D.2
Mahanivong, C.3
Cheng, R.K.4
Zhou, W.5
Huang, S.6
-
63
-
-
0035930504
-
v Integrin, p38 Mitogen-activated Protein Kinase, and Urokinase Plasminogen Activator Are Functionally Linked in Invasive Breast Cancer Cells
-
Chen J, Baskerville C, Han Q, Pan ZK and Huang S: Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells. J Biol Chem 276: 47901-47905, 2001. (Pubitemid 37370687)
-
(2001)
Journal of Biological Chemistry
, vol.276
, Issue.51
, pp. 47901-47905
-
-
Chen, J.1
Baskerville, C.2
Han, Q.3
Pan, Z.K.4
Huang, S.5
-
64
-
-
15444368022
-
Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells
-
DOI 10.1074/jbc.M412152200
-
Li H, Ye X, Mahanivong C, Bian D, Chun J and Huang S: Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. J Biol Chem 280: 10564-10571, 2005. (Pubitemid 40395917)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.11
, pp. 10564-10571
-
-
Li, H.1
Ye, X.2
Mahanivong, C.3
Bian, D.4
Chun, J.5
Huang, S.6
-
65
-
-
0029907265
-
A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation
-
DOI 10.1038/383547a0
-
Dikic I, Tokiwa G, Lev S, Courtneidge SA and Schlessinger J: A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550, 1996. (Pubitemid 26346184)
-
(1996)
Nature
, vol.383
, Issue.6600
, pp. 547-550
-
-
Dikic, I.1
Tokiwa, G.2
Lev, S.3
Courtneidge, S.A.4
Schlessinger, J.5
-
66
-
-
1542305671
-
Transforming Growth Factor-beta1-dependent Urokinase Up-regulation and Promotion of Invasion Are Involved in Src-MAPK-dependent Signaling in Human Ovarian Cancer Cells
-
DOI 10.1074/jbc.M309131200
-
Tanaka Y, Kobayashi H, Suzuki M, Kanayama N and Terao T: Transforming growth factor-beta1-dependent urokinase upregulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem 279: 8567-8576, 2004. (Pubitemid 38295910)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.10
, pp. 8567-8576
-
-
Tanaka, Y.1
Kobayashi, H.2
Suzuki, M.3
Kanayama, N.4
Terao, T.5
-
67
-
-
0035866381
-
Upregulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase
-
Dunn SE, Torres JV, Oh JS, Cykert DM and Barrett JC: Upregulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res 61: 1367-1374, 2001.
-
(2001)
Cancer Res
, vol.61
, pp. 1367-1374
-
-
Dunn, S.E.1
Torres, J.V.2
Oh, J.S.3
Cykert, D.M.4
Barrett, J.C.5
-
68
-
-
0032697491
-
Regulation by p38 mitogen-activated protein kinase of adenylate- And uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion
-
Montero L and Nagamine Y: Regulation by p38 mitogenactivated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Cancer Res 59: 5286-5293, 1999. (Pubitemid 29503996)
-
(1999)
Cancer Research
, vol.59
, Issue.20
, pp. 5286-5293
-
-
Montero, L.1
Nagamine, Y.2
|